Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain

  • 1, 2, 3Email author,
  • 1, 17,
  • 1, 18,
  • 4,
  • 5, 6,
  • 1,
  • 1,
  • 7,
  • 8,
  • 4, 9,
  • 10,
  • 11,
  • 12,
  • 13,
  • 5, 6,
  • 1,
  • 8,
  • 7,
  • 14,
  • 15,
  • 1,
  • 7,
  • 14,
  • 1,
  • 10,
  • 1,
  • 10,
  • 8,
  • 3 and
  • 1, 16Email author
Molecular Neurodegeneration201611:42

https://doi.org/10.1186/s13024-016-0105-4

  • Received: 11 May 2016
  • Accepted: 12 May 2016
  • Published:

The original article was published in Molecular Neurodegeneration 2016 11:31

Unfortunately, after publication of this article [1], it was noticed that the name of Matan Hofree was misspelled. The corrected name can be seen above and the original article has been updated to reflect this change.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
(2)
Institute of Chemistry and Biochemistry, Free University, Berlin, Berlin, Germany
(3)
Departments of Bioengineering and Medicine, University of California, La Jolla, San Diego, CA, USA
(4)
Department of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA
(5)
RayBiotech, Guangzhou, China
(6)
RayBiotech, Norcrosse, GA, USA
(7)
Department of Neurology, Mayo Clinic, Rochester, MN, USA
(8)
Department of Neurology, University of California San Francisco, San Francisco, CA, USA
(9)
Departments of Neurology, Ophthalmology, Genetics and Genomics, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, MA, USA
(10)
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
(11)
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
(12)
Departments of Pharmacology and Nutritional Sciences and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA
(13)
Department of Computer Science and Engineering, University of California, La Jolla, San Diego, CA, USA
(14)
Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA
(15)
Department of Pathology, University of California, La Jolla, San Diego, CA, USA
(16)
Center for Tissue Regeneration, Repair and Restoration, VA Palo Alto Health Care System, Palo Alto, CA, USA
(17)
Present address: Biology Department, Eastern Connecticut State University, Willimantic, CT, USA
(18)
Present address: Roche Pharma Research and Early Development, NORD DTA, Roche Innovation, Center Basel, Basel, Switzerland

Reference

  1. Jaeger PA, Lucin KM, Britschgi M, Vardarajan B, Huang R-P, Kirby ED, Abbey R, Boeve BF, Boxer AL, Farrer LA, Finch N, Graff-Radford NR, Head E, Hofree M, Huang R, Johns H, Karydas A, Knopman DS, Loboda A, Masliah E, Narasimhan R, Petersen RC, Podtelezhnikov A, Pradhan S, Rademakers R, Sun C-H, Younkin SG, Miller BL, Ideker T, Wyss-Coray T. Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain. Mol Neurodegener. 2016;11:31. doi:10.1186/s13024-016-0095-2.

Copyright

Advertisement